Complete mesocolic excision for colon cancer: is now the time for a change in practice?
Menée à partir de données portant sur 1 069 patients traités par chirurgie élective à visée curative pour un cancer du côlon droit de stade I à III (durée de suivi après traitement : 5,2 ans), cette étude multicentrique évalue le taux cumulé de récidive après une résection mésocolique complète
Complete mesocolic excision for colon cancer has gained increasing popularity over recent years following publication of the Erlangen experience in 2009. The investigators of this study standardised their surgical approach for potentially curative disease, leading to a reduction in local recurrence (from 6·5% to 3·6%) and improvement in cancer-related 5-year survival (from 82·1% to 89·1%) over a 24-year period. Complete mesocolic excision is based on similar principles to total mesorectal excision for rectal cancer, a technique now considered the international gold standard. Total mesorectal excision has led to substantial improvements in outcomes through removal of the tumour in an intact package containing all major routes of dissemination.
The Lancet Oncology , commentaire, 2018